Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 1

Normal pressure hydrocephalus co-existing with a second dementia disorder

Authors Alisky J

Published 8 February 2008 Volume 2008:4(1) Pages 301—304


Joseph Alisky1,2

1Marshfield Clinic Research Foundation, 1000 Oak Avenue, Marshfield, Wisconsin, USA; 2Marshfield Clinic Thorp Center, 704 South Clark, Thorp, Wisconsin, USA

Abstract: An 87-year-old woman had both Lewy body dementia and normal pressure hydrocephalus simultaneously. One should not automatically exclude the possibility of normal pressure hydrocephalus simply because another neurodegenerative disorder is present, especially if the second disorder masks typical symptoms of normal pressure hydrocephalus. Better identification of dual diagnosis patients could lead to improvements in gait and incontinence following ventriculoperitoneal or lumboperitoneal shunting, even if the natural history of the other neurodegenerative disease remains unchanged.

Keywords: dementia, gait disorder, normal pressure hydrocephalus, Lewy body dementia, ventriculoperitoneal shunt

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Hematuria following Botox treatment for upper limb spasticity: a case report

Lo TC, Yeung ST, Lee S, Chang EY

Journal of Pain Research 2015, 8:619-622

Published Date: 14 September 2015

Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer

Lin GW, Ye DW, Jia HX, Dai B, Zhang HL, Zhu Y, Shi GH, Ma CG

OncoTargets and Therapy 2015, 8:713-719

Published Date: 7 April 2015

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

Hong SD, Fang WF, Liang WH, Yan Y, Zhou T, Qin T, Wu X, Ma YX, Zhao YY, Yang YP, Hu ZH, Xue C, Hou X, Chen Y, Huang Y, Zhao HY, Zhang L

OncoTargets and Therapy 2014, 7:1851-1867

Published Date: 7 October 2014

Polyhydroxylated fullerene attenuates oxidative stress-induced apoptosis via a fortifying Nrf2-regulated cellular antioxidant defence system

Ye SF, Chen M, Jiang YQ, Chen ML, Zhou T, Wang YG, Hou ZQ, Ren L

International Journal of Nanomedicine 2014, 9:2073-2087

Published Date: 29 April 2014

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer

Sun S, Tang L, Zhang J, Lv F, Wang Z, Wang L, Zhang Q, Zheng C, Qiu L, Jia Z, Lu Y, Liu G, Shao Z, Wang B, Hu X

International Journal of Nanomedicine 2014, 9:1443-1452

Published Date: 19 March 2014

Remembering and forgetting: directed forgetting effect in obsessive-compulsive disorder

Konishi M, Shishikura K, Nakaaki S, Komatsu S, Mimura M

Neuropsychiatric Disease and Treatment 2011, 7:365-372

Published Date: 15 June 2011

Age-related changes of ocular parameters in Korean subjects

Dae Woong Lee, Joon Mo Kim, Chul Young Choi, et al

Clinical Ophthalmology 2010, 4:725-730

Published Date: 7 July 2010

Risperidone treatment for ADHD in children and adolescents with bipolar disorder

Joseph Biederman, Paul Hammerness, Robert Doyle, Gagan Joshi, Megan Aleardi, Eric Mick

Neuropsychiatric Disease and Treatment 2008, 4:203-207

Published Date: 8 February 2008

The relationship between dementia severity and rest/activity circadian rhythms

Phil Gehrman, Matthew Marler, Jennifer L Martin, Tamar Shochat, Jody Corey-Bloom, Sonia Ancoli-Israel

Neuropsychiatric Disease and Treatment 2005, 1:155-163

Published Date: 15 July 2005